Comparing Message-Based Psychotherapy to Once-Weekly, Video-Based Psychotherapy for Moderate Depression: Randomized Controlled Trial.
Burden of Disease
anxiety
depression
functional impairment, credibility, alliance, engagement
intervention
mental health
message therapy
message-based psychotherapy
randomized controlled trial
telehealth
telemedicine
text mining
video-based psychotherapy
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
29 06 2023
29 06 2023
Historique:
received:
27
01
2023
accepted:
23
05
2023
revised:
03
05
2023
medline:
3
7
2023
pubmed:
29
6
2023
entrez:
29
6
2023
Statut:
epublish
Résumé
Despite the high prevalence of major depressive disorder and the related societal burden, access to effective traditional face-to-face or video-based psychotherapy is a challenge. An alternative that offers mental health care in a flexible setting is asynchronous messaging therapy. To date, no study has evaluated its efficacy and acceptability in a randomized controlled trial for depression. The aim of this study was to compare the efficacy and acceptability of message-based psychotherapy for depression to once-weekly video-based psychotherapy. In this 2-armed randomized controlled trial, individuals (N=83) with depressive symptomatology (Patient Health Questionnaire-9 ≥10) were recruited on the internet and randomly assigned to either a message-based intervention group (n=46) or a once-weekly video-based intervention group (n=37). Patients in the message-based treatment condition exchanged asynchronous messages with their therapist following an agreed-upon schedule. Patients in the video-based treatment condition met with their therapist once each week for a 45-minute video teletherapy session. Self-report data for depression, anxiety, and functional impairment were collected at pretreatment, weekly during treatment, at posttreatment, and at a 6-month follow-up. Self-reported treatment expectancy and credibility for the assigned intervention were assessed at pretreatment and therapeutic alliance at posttreatment. Findings from multilevel modeling indicated significant, medium-to-large improvements in depression (d=1.04; 95% CI 0.60-1.46), anxiety (d=0.61; 95% CI 0.22-0.99), and functional impairment (d=0.66; 95% CI 0.27-1.05) for patients in the message-based treatment condition. Changes in depression (d=0.11; 95% CI -0.43 to 0.66), anxiety (d=-0.01; 95% CI -0.56 to 0.53), and functional impairment (d=0.25; 95% CI -0.30 to 0.80) in the message-based treatment condition were noninferior to those in the video-based treatment condition. There were no significant differences in treatment credibility (d=-0.09; 95% CI -0.64 to 0.45), therapeutic alliance (d=-0.15; 95% CI -0.75 to 0.44), or engagement (d=0.24; 95% CI -0.20 to 0.67) between the 2 treatment conditions. Message-based psychotherapy could present an effective and accessible alternative treatment modality for patients who might not be able to engage in traditional scheduled services such as face-to-face or video-based psychotherapy. ClinicalTrials.gov NCT05467787; https://www.clinicaltrials.gov/ct2/show/NCT05467787.
Sections du résumé
BACKGROUND
Despite the high prevalence of major depressive disorder and the related societal burden, access to effective traditional face-to-face or video-based psychotherapy is a challenge. An alternative that offers mental health care in a flexible setting is asynchronous messaging therapy. To date, no study has evaluated its efficacy and acceptability in a randomized controlled trial for depression.
OBJECTIVE
The aim of this study was to compare the efficacy and acceptability of message-based psychotherapy for depression to once-weekly video-based psychotherapy.
METHODS
In this 2-armed randomized controlled trial, individuals (N=83) with depressive symptomatology (Patient Health Questionnaire-9 ≥10) were recruited on the internet and randomly assigned to either a message-based intervention group (n=46) or a once-weekly video-based intervention group (n=37). Patients in the message-based treatment condition exchanged asynchronous messages with their therapist following an agreed-upon schedule. Patients in the video-based treatment condition met with their therapist once each week for a 45-minute video teletherapy session. Self-report data for depression, anxiety, and functional impairment were collected at pretreatment, weekly during treatment, at posttreatment, and at a 6-month follow-up. Self-reported treatment expectancy and credibility for the assigned intervention were assessed at pretreatment and therapeutic alliance at posttreatment.
RESULTS
Findings from multilevel modeling indicated significant, medium-to-large improvements in depression (d=1.04; 95% CI 0.60-1.46), anxiety (d=0.61; 95% CI 0.22-0.99), and functional impairment (d=0.66; 95% CI 0.27-1.05) for patients in the message-based treatment condition. Changes in depression (d=0.11; 95% CI -0.43 to 0.66), anxiety (d=-0.01; 95% CI -0.56 to 0.53), and functional impairment (d=0.25; 95% CI -0.30 to 0.80) in the message-based treatment condition were noninferior to those in the video-based treatment condition. There were no significant differences in treatment credibility (d=-0.09; 95% CI -0.64 to 0.45), therapeutic alliance (d=-0.15; 95% CI -0.75 to 0.44), or engagement (d=0.24; 95% CI -0.20 to 0.67) between the 2 treatment conditions.
CONCLUSIONS
Message-based psychotherapy could present an effective and accessible alternative treatment modality for patients who might not be able to engage in traditional scheduled services such as face-to-face or video-based psychotherapy.
TRIAL REGISTRATION
ClinicalTrials.gov NCT05467787; https://www.clinicaltrials.gov/ct2/show/NCT05467787.
Identifiants
pubmed: 37384392
pii: v25i1e46052
doi: 10.2196/46052
pmc: PMC10365600
doi:
Banques de données
ClinicalTrials.gov
['NCT05467787']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e46052Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Informations de copyright
©Jiyoung Song, Boris Litvin, Ryan Allred, Shiyu Chen, Thomas D Hull, Patricia A Areán. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 29.06.2023.
Références
NPJ Digit Med. 2019 Jun 17;2:54
pubmed: 31304400
J Clin Psychol. 1986 Jul;42(4):562-9
pubmed: 3745453
Cyberpsychol Behav Soc Netw. 2013 May;16(5):370-7
pubmed: 23530546
J Anxiety Disord. 1997 May-Jun;11(3):221-40
pubmed: 9220298
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Health Aff (Millwood). 2018 Dec;37(12):1975-1982
pubmed: 30633674
Telemed J E Health. 2017 Mar;23(3):240-247
pubmed: 27797646
J Clin Transl Sci. 2020 May 04;4(5):463-467
pubmed: 33244437
Curr Psychiatry Rep. 2018 Aug 28;20(10):85
pubmed: 30155593
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
BMC Psychiatry. 2020 Jun 12;20(1):297
pubmed: 32532225
Clin Psychol Rev. 2020 Dec;82:101921
pubmed: 33069096
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Clin Psychol Psychother. 2010 May-Jun;17(3):231-9
pubmed: 20013760
Clin Psychol Rev. 2015 Aug;40:57-65
pubmed: 26067572
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
J Consult Clin Psychol. 1977 Dec;45(6):1052-9
pubmed: 21894
Front Digit Health. 2022 Feb 10;4:840169
pubmed: 35224537
Clin Orthop Surg. 2014 Mar;6(1):103-9
pubmed: 24605197
MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):306-312
pubmed: 35202357
J Affect Disord. 2021 Jan 1;278:131-135
pubmed: 32956962
J Consult Clin Psychol. 1993 Aug;61(4):611-9
pubmed: 8370856
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
BMJ Open. 2021 Nov 2;11(11):e046958
pubmed: 34728440
JMIR Ment Health. 2015 Mar 16;2(1):e4
pubmed: 26543910
Am Psychol. 2021 Jan;76(1):14-25
pubmed: 32816503